VEGFA and metastatic colorectal cancer: Given the data supporting the efficacy of bevacizumab therapy in metastatic colorectal cancer [17], it was postulated that combining bevacizumab with chemoradiation may increase antitumour efficacy by maximizing inhibition of the VEGF pathway.